amorcyte amorcyte amorcyte amorcyte amorcyte
amorcyte amorcyte amorcyte amorcyte amorcyte
amorcyte amorcyte
Amorcyte Logo Cell Therapy Solutions for Cardiovascular Disease amorcyte home amorcyte contact us amorcyte
amorcyte amorcyte
amorcyte amorcyte
amorcyte amorcyte
amorcyte
amorcyte
amorcyte
Bernard J. Gersh, MB ChB, D.Phil
Professor of Medicine at Mayo Clinic of Medicine and Consultant in Cardiovascular Diseases
amorcyte
amorcyte
amorcyte
Dean J. Kereiakes, MD
Medical Director of the Heart Center of Greater Cincinnati at Christ Hospital
amorcyte
amorcyte
amorcyte
Emerson C. Perin, MD, PhD, FACC
Director, New Interventional Cardiovascular Technology, Texas Heart Institute
amorcyte
amorcyte
amorcyte
Arshed A. Quyyumi, MD, FRCP, FACC
Professor of Medicine, Cardiology, Emory University School of Medicine
amorcyte
amorcyte
amorcyte
Edmund Waller, MD, PhD, FACP
Professor of Medicine at Emory Health Care Division of Cardiology
amorcyte
amorcyte
amorcyte
Ned Waller, MD
Professor of Medicine, Hematology and Stem Cell Biology, Emory University School of Medicine
amorcyte
amorcyte
amorcyte
James T. Willerson, MD
President of the University of Texas Health Science Center
amorcyte
amorcyte
amorcyte
Ching Zhu, PhD, MBA
Partner, PA Early Stage Partners, Former Manager, Emerging Therapy Research, Guidant Corp.
amorcyte
amorcyte
amorcyte

amorcyte
amorcyte amorcyte
amorcyte amorcyte
amorcyte amorcyte amorcyte
Back to Top
amorcyte amorcyte
amorcyte amorcyte amorcyte amorcyte amorcyte